Consumers of mental health services

Suicide and Life-Threatening Behavior

Volumn 31, Issue 1 SUPPL., 2001, Pages 60-83

  Roy, A ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOZAPINE; DOSULEPIN; HALOPERIDOL; IMIPRAMINE; LITHIUM; METHADONE; NALTREXONE; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM;

ALCOHOLISM; BORDERLINE STATE; CONSUMER; DEPRESSION; DRUG DEPENDENCE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; MENTAL HEALTH SERVICE; PREVALENCE; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SUICIDE;

EID: 0035050932     PISSN: 03630234     EISSN: None     Source Type: Journal    
DOI: 10.1521/suli.31.1.5.60.24222     Document Type: Review

References (138)

1. Suicidal behavior in schizophrenia and it's relationship to awareness of illness
2. Suicide in psychiatric patients: Risk and prevention
3. Biologic alternations in the brain stems of suicides
4. Retrospective psychiatric assessments of 200 suicides in Budapest
5. Neurotransmitters and suicidal behavior: The evidence from cerebrospinal fluid studies
6. Suicidal behavior in adult psychiatric outpatients
7. A hundred cases of suicide: Clinical aspects
8. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts
9. Unemployment and serious suicide attempts
10. Graduate training in clinical psychology and the study of suicide
11. Time series analysis of alcohol consumption and suicide mortality in the United States, 1934-1987
12. Schizophrenia - A high risk factor for suicide: Clues to risk reduction
13. Suicide in Brisbane: A retrospective psychosocial study
14. Fluoxetine and impulsive aggressive behavior in personality - Disordered subjects
15. Relationship of age and axis I diagnoses in victims of completed suicide: A psychological autopsy study
16. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial
17. Disproportionate suicidality in patients with comorbid major depression and alcoholism
18. The association of sexual assault and attempt and attempted suicide within the community
19. A study of suicide in the Seattle area
20. Depression, hopelessness and suicide in chronic schizophrenia
21. Patient suicide in psychiatry residency programs. A national survey of training and postvention practices
22. Manual assisted cognitive-behavior therapy (MACT): A randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm
23. Suicide: A four - Pathway clinical biochemical model
24. Symptoms, subtype and suicidality in patients with schizophrenia spectrum disorders
25. Recovery from major depression is not associated with normalization of serotonergic function
26. Suicide after discharge from psychiatric inpatient care
27. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders
28. Assessment and intervention for the suicidal patient with schizophrenia
29. Suicide as an outcome for mental disorders
30. Deliberate self-harm: Systematic review efficacy of psychosocial and pharmacological treatments in preventing repetition
31. Suicide and schizophrenia
32. Mental disorders and comorbidity in suicide
33. Panic disorder in complete suicide
34. Assessment and treatment of suicidal patients
35. Borderline personality disorder and impulsive - Aggression: The role for divalproex sodium treatment
36. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia
37. Epidemiological data suggest antidepressants reduce suicide risk among depressives
38. The utilization of antidepressants - A key issue in the prevention of suicide: An analysis of 5281 suicides in Sweden during the period 1992-1994
39. Suicide in major depression
40. Suicide among subjects with personality disorder
41. Chapter Suicide
42. Positive and negative symptoms as risk factors for later suicidal activity in schizophrenics versus depressives
43. Strategies for preventing suicide
44. Behavioral treatments of suicidal behaviors
45. Cognitive-behavioral treatment of chronically parasuicidal borderline patients
46. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients
47. Suicide prevention in young adults (aged 18-30)
48. Suicide prevention in a treatment setting
49. Clinical assessment versus research methods in the assessment of suicidal behavior
50. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients
51. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy
52. Toward a clinical model of suicidal behavior in psychiatric patients
53. Postscript: Summary and synthesis
54. A double-blind placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression
55. Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period
56. Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial
57. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment
58. Suicide prevention: Spreading the gospel to general practioners
59. Assessment of risk
60. Epidemiology of suicidal behavior
61. Suicide attempts in the Epidemiologic Catchman Area study
62. Pharmacologic prevention of suicidal behavior
63. Suicide and antidepressants
64. Suicide prevention
65. Suicide prevention for high-risk persons who refuse treatment
66. Childhood sexual abuse and mental health in adult life
67. The physician's responsibility for suicide I. An error of commission
68. The physician's responsibility for suicide II Errors of omission
69. On suicide prediction and prevention
70. The physician's role in suicide prevention
71. Suicide in alcoholism
72. Thirty-nine years of suicide research: A personal view
73. Suicide and alcoholism
74. The lifetime risk of suicide in alcoholism
75. Multiple risk factors predict suicide in alcoholism
76. Association of maternal, antenatal and perinatal complications with suicide in adolescence and young adulthood
77. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan dydroxylase polymorphism
78. A tryptophan hydroxylase marker for suicidality and alcoholism
79. CSF 5-HIAA predicts suicide risk after attempted suicide
80. Attempted suicide predicts suicide risk in mood disorders
81. Survival analysis of suicide risk after attempted suicide
82. Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial
83. Naltrexoride and coping skills therapy for alcohol dependence. A controlled study
84. Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior
85. Altered serotonin function in suicide: Evidence from platelet and neuroendocrine studies
86. Completed suicide in borderline personality disorder
87. Prediction of suicide in psychiatric patients. Report of a prospective study
88. Suicide prevention from a public health perspective
89. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study
90. San Diego Suicide Study. I: Young vs. old subjects
91. The communication of suicidal intent: A study of 134 consecutive cases of successful (completed) suicide
92. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides
93. Risk factors for suicide in patients with schizophrenia: Nested case-control study
94. Risk factors for suicide in psychiatric patients
95. Suicide in chronic schizophrenia
96. Family history of suicide
97. Depression, attempted suicide and suicide in patients with chronic schizophrenia
98. Aetiology of secondary depression in male alcoholics
99. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics
100. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients: A five-year follow-up study
101. Suicide among psychiatric hospital in-patients
102. Alcoholism and suicide
103. Depression in alcoholism
104. Attempted suicide in chronic schizophrenia
105. Genetics of suicide: Family studies and molecular genetics
106. Suicide in twins
107. Attempted living cotwins of twin suicide victims
108. Suicidal behavior in schizophrenic patients: A follow-up study
109. Diagnostic comorbidity of mental disorders among young suicides
110. Frequency of suicide on Gotland after systematic postgraduate education of general practitioners
111. An educational program on depressive disorders for general practitioners on Gotlan: Background and evaluation
112. The effectiveness of fluoxetine, nortiptyline and desipramine in major depressives with suicidal behavior: Preliminary findings
113. The epidemiology of suicide
114. Cognitive-behavioral problem solving in the treatment of patients who repeatedly attempt suicide. A controlled trial
115. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder
116. Relapse prevention by acamprosate
117. A ten-year review of the validity and clinical utility of depression screening
118. Social Phobia comorbidity and morbidity in an epidemiologic sample
119. Did manic-depressive patients who committed suicide receive prophylactic or continuation treatment at the time?
120. A family study of suicide
121. The place of suicide prevention in the spectrum of intervention: Definitions of critical terms and constructs
122. The prevention of suicidal behavior: An overview
123. Assessment and treatment of depression in schizophrenia
124. Suicide rates among current and former mental institution patients
125. Effects of lithium maintenance on suicidal behavior in major mood disorders
126. Depressive signs and symptoms in schizophrenia. A prospective blinded trial of olanzapine and holoperidol
127. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
128. Monoamine metabilites in CSF and suicidal behavior
129. Childhood origins of self-destructive behavior
130. Suicides in the former Soviet republics
131. Suicide in Estonia
132. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression
133. Naltrexone in the treatment of alcohol dependence
134. Suicidal ideation and suicide attempts in panic disorder and attacks
135. Practice guideline for Major Depressive Disorder in Adults